RU2004122024A - AIDS TREATMENT - Google Patents

AIDS TREATMENT Download PDF

Info

Publication number
RU2004122024A
RU2004122024A RU2004122024/14A RU2004122024A RU2004122024A RU 2004122024 A RU2004122024 A RU 2004122024A RU 2004122024/14 A RU2004122024/14 A RU 2004122024/14A RU 2004122024 A RU2004122024 A RU 2004122024A RU 2004122024 A RU2004122024 A RU 2004122024A
Authority
RU
Russia
Prior art keywords
receptors
hemosorption
stage
carried out
blood
Prior art date
Application number
RU2004122024/14A
Other languages
Russian (ru)
Other versions
RU2285529C2 (en
Inventor
Юрий Владимирович Лобзин (RU)
Юрий Владимирович Лобзин
Виктор Николаевич Александров (RU)
Виктор Николаевич Александров
Борис Лаврович Макеев (RU)
Борис Лаврович Макеев
Original Assignee
Военно-медицинска академи им. С.М. Кирова (RU)
Военно-медицинская академия им. С.М. Кирова
Юрий Владимирович Лобзин (RU)
Юрий Владимирович Лобзин
Виктор Николаевич Александров (RU)
Виктор Николаевич Александров
Борис Лаврович Макеев (RU)
Борис Лаврович Макеев
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Военно-медицинска академи им. С.М. Кирова (RU), Военно-медицинская академия им. С.М. Кирова, Юрий Владимирович Лобзин (RU), Юрий Владимирович Лобзин, Виктор Николаевич Александров (RU), Виктор Николаевич Александров, Борис Лаврович Макеев (RU), Борис Лаврович Макеев filed Critical Военно-медицинска академи им. С.М. Кирова (RU)
Priority to RU2004122024/14A priority Critical patent/RU2285529C2/en
Publication of RU2004122024A publication Critical patent/RU2004122024A/en
Application granted granted Critical
Publication of RU2285529C2 publication Critical patent/RU2285529C2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)

Claims (1)

Способ лечения СПИД, включающий поэтапное лечение, при котором на первом этапе поочередно вводят ингибитор и активатор репликации; на втором этапе осуществляют гемосорбцию, на третьем осуществляют реабилитацию иммунной системы с использованием крови, обогащенной стволовыми клетками, и специфическую иммуностимуляцию, отличающийся тем, что гемосорбцию осуществляют с использованием колонок, каждая из которых содержит матрицу с иммобилизированными на агарозе лигандами, включающими соответственно: первая - специфические противовирусные антитела, вторая - СД4-рецепторы, третья - рецепторы к гамма-интерферрону, четвертная - рецепторы к Fc-фрагменту иммуногблобулина G, пятая - антимикробные белки животного происхождения; а обогащенную стволовыми клетками кровь вводят внутривенно.A method of treating AIDS, including phased treatment, in which at the first stage, an inhibitor and an activator of replication are alternately administered; at the second stage, hemosorption is carried out, at the third, the immune system is rehabilitated using blood enriched with stem cells, and specific immunostimulation, characterized in that hemosorption is carried out using columns, each of which contains a matrix with ligands immobilized on agarose, including, respectively: the first - specific antiviral antibodies, the second — CD4 receptors, the third — receptors for gamma interferron, the fourth — receptors for the Fc fragment of immunoglobulin G, fifth The first - the antimicrobial proteins of animal origin; and stem cell enriched blood is administered intravenously.
RU2004122024/14A 2004-07-16 2004-07-16 Method for treatment of aids RU2285529C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2004122024/14A RU2285529C2 (en) 2004-07-16 2004-07-16 Method for treatment of aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004122024/14A RU2285529C2 (en) 2004-07-16 2004-07-16 Method for treatment of aids

Publications (2)

Publication Number Publication Date
RU2004122024A true RU2004122024A (en) 2006-02-10
RU2285529C2 RU2285529C2 (en) 2006-10-20

Family

ID=36049254

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004122024/14A RU2285529C2 (en) 2004-07-16 2004-07-16 Method for treatment of aids

Country Status (1)

Country Link
RU (1) RU2285529C2 (en)

Also Published As

Publication number Publication date
RU2285529C2 (en) 2006-10-20

Similar Documents

Publication Publication Date Title
FR22C1052I2 (en) HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN THE TREATMENT OF TUMORS, TRANSPLANTATION AND AUTOIMMUNE DISEASES
Golembeski et al. Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice
Bingaman et al. Single-center kidney paired donation: the Methodist San Antonio experience
EA201000245A1 (en) HUMAN NEUTRALIZING ANTIBODIES TO THE NERVE GROWTH FACTOR (NGF) AS A SELECTIVE NGF METABOLIC INHIBITOR
Goldstein History of the discovery of the thymosins
SI1835937T1 (en) Compositions and methods for treating viral infection
LUC00053I9 (en) ANTIBODIES AGAINST CD38 FOR THE TREATMENT OF MULTIPLE MYELOMA
NO20052220L (en) Methods for treating Alzheimer's disease using antibodies directed to amyloid beta-peptide and preparations thereof
EA200500441A1 (en) THERAPEUTIC HUMAN MONOCLONAL ANTIBODY AGAINST IL-1R1
NO20056027L (en) Surrogate therapeutic endpoint for anti-CTLA-4 based disease immunotherapy
NO20090069L (en) Targeted compounds targeting binding to PDGFR-alpha and their use
JP2018135370A (en) Combined pharmaceutical composition and method for treating and preventing infectious disease
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
TW200626614A (en) Human monoclonal antibodies to influenza M2 protein and methods of making and using same
DK1684805T3 (en) Use of antagonist anti-CD40 monoclonal antibodies to treat multiple myeloma
MA31225B1 (en) Tie cytomegalovirus for human antibody cells and use.
RU2013105769A (en) BIOLOGICAL MATERIALS AND THEIR APPLICATION
MX2010006181A (en) Anti-human il-21 monoclonal antibodies.
MA31312B1 (en) Antibody anti-ig notepad.
BR0011838B1 (en) saddle element and static mixer structure.
SG170749A1 (en) Anti-ilt7 antibody
AR067199A1 (en) PROTEINS OF UNION TO ANTIGENS THAT JOIN PAR-2
ATE497392T1 (en) THERAPY WITH ANTI-CD4 ANTIBODIES AND RADIATION
JP2013537539A5 (en)
RU2013110844A (en) ANTIBODIES AGAINST IL-1β AND IL-18 USED FOR TREATMENT OF DISEASES

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070717